UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000015405
Receipt No. R000017596
Scientific Title A randomized, phase III trial of sequential capecitabine/5FU plus bevacizumab (Cape/5FU-Bmab) to capecitabine/5FU plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer.
Date of disclosure of the study information 2014/10/14
Last modified on 2019/02/22 13:07:56

No. Disposal Last modified on Item of update
1 Insert 2014/10/10 15:26:22
2 Update 2014/10/14 13:22:54 Recruitment status
3 Update 2014/10/14 13:23:36 Date of disclosure of the study information
4 Update 2014/11/17 10:17:59 Organization
Name of secondary funder(s)
Name of secondary funder(s)
5 Update 2014/12/05 17:24:00 Recruitment status
6 Update 2014/12/07 10:56:58 Category of Funding Organization
7 Update 2016/10/11 13:23:59 Recruitment status
8 Update 2019/02/22 13:07:56 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete

Contact us.